Key facts
- It has raised $13.7M across 2 recorded rounds; the latest was Seed Round ($1.5M) in Jun 2023.
- Notable investors include BlueWater Angels, Excell Partners, Hopelab, Mason Argiropoulos, NextCorps.
- GRYT Health has filed 2 Form Ds with the SEC since 2021, most recently Jan 2024 ($1.5M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for GRYT Health
Funding rounds
2 roundsAbout GRYT Health
Operator of a digital health company intended to improve health outcomes for those facing cancer or other chronic illnesses. The company platforms help in patient data, research analytics, clinical trial recruitment, and patient education and marketing services to pharmaceutical companies from drug development through the commercialization life cycle, enabling people to be in charge of their health.
- Sector
- Healthcare
- HQ
- Rochester, NY, United States
- Founded
- 2015
- Employees
- 17
- Website
- grythealth.com/
- Ownership
- Privately Held (backing)
GRYT Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GRYT Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GRYT Health in its N-PORT filings yet. We sweep new filings monthly.